Remedly
PrivateLast Round
Series A
Mar 9, 2021
Est. Valuation
$11.93M
Total Funding Raised
$6.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Remedly is a healthcare software company that provides an all-in-one, cloud-based platform combining Electronic Health Records (EHR), Revenue Cycle Management (RCM), and practice management solutions for specialty medical practices.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Patient Engagement, Revenue Cycle, Fashion & Beauty
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedly Comparables
Compare Remedly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prospyr Medical, Inc. | 91% | |
| Symplast | 91% | |
| Aesthetic Record | 90% | |
Remedly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2021 | ||||
| Series A | Oct 20, 2020 | ||||
| Seed | Mar 10, 2017 | ||||
| Accelerator | Mar 9, 2017 |
Remedly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed, Accelerator |
| FCA Venture Partners | Series A |
| Ulu Ventures | Series A |
| LEO Innovation Lab | Series A, Seed, Accelerator |
| Healthbox | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Jun 23, 2026
Grew 25% QoQ, from 12 to 15 employees.
Remedly Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remedly's valuation, stock price, and market status.